The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

US Court Blocks Mail-order Access to Abortion Drugs, for Now

A U.S. appeals court on Friday temporarily blocked a federal rule allowing the abortion drug mifepristone to be dispensed through the mail, significantly curtailing access...

Does AD Affect Adults More With Early Onset Than With Later?

Patients with atopic dermatitis since childhood show a greater psychosocial burden than those with the disease since adolescence; however, no variation in allergic comorbidities is observed.

Triple Therapy for Asthma Earns FDA Approval

Evidence of reduced exacerbations and improved lung function supported the additional indication.

Noninvasive Tests Key to Identifying MASH in Primary Care

As the prevalence of liver disease continues to climb alongside diabetes and obesity, the role of the primary care physician is evolving from referral maker to frontline manager.

New CAR-T Cell Method May Allow Some Cancer Patients to Skip Chemotherapy

We also report on a new use for artificial intelligence that could help eliminate some racial inequities in heart disease diagnoses.

Are Food Allergies Overdiagnosed in Black Patients?

Despite higher levels of specific IgE, Black patients undergo oral food challenge tests far less often than White patients and are more likely to tolerate them, indicating possible overdiagnosis.

Todays Updates

Practice-Changing Ovarian Cancer Updates From SGO 2026

Dr Bradley Corr reviews data on the NRG-GY019 and ROSELLA trials, and discusses their clinical impact on ovarian cancer care.

Data Trends: Heart Failure

Up to 15 million Americans are at risk of heart failure, with mortality rates rising in the US.

Missed Sexual Health Assessment May Limit Clinical Insight

New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.

US Supreme Court Lets Abortion Pill Mail Delivery Restart for Now

The U.S. Supreme Court temporarily reinstated on Monday a federal rule allowing the abortion pill to be prescribed through telemedicine and dispensed through the mail,...

When Retirement Triggers Risk: Substance Use in Older Adults

Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.

Personalized Stimulation Boosts Outcomes in Essential Tremor

Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.

Adjunctive CBD Improves Neuropsychiatric Symptoms in TSC

Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.

Todays Updates

Practice-Changing Ovarian Cancer Updates From SGO 2026

Dr Bradley Corr reviews data on the NRG-GY019 and ROSELLA trials, and discusses their clinical impact on ovarian cancer care.

Data Trends: Heart Failure

Up to 15 million Americans are at risk of heart failure, with mortality rates rising in the US.

Missed Sexual Health Assessment May Limit Clinical Insight

New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.

US Supreme Court Lets Abortion Pill Mail Delivery Restart for Now

The U.S. Supreme Court temporarily reinstated on Monday a federal rule allowing the abortion pill to be prescribed through telemedicine and dispensed through the mail,...

When Retirement Triggers Risk: Substance Use in Older Adults

Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.

Personalized Stimulation Boosts Outcomes in Essential Tremor

Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.

Adjunctive CBD Improves Neuropsychiatric Symptoms in TSC

Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.

Latest News

A U.S. appeals court on Friday temporarily blocked a federal rule allowing the abortion drug mifepristone to be dispensed through the mail, significantly curtailing access...

Patients with atopic dermatitis since childhood show a greater psychosocial burden than those with the disease since adolescence; however, no variation in allergic comorbidities is observed.

Evidence of reduced exacerbations and improved lung function supported the additional indication.

As the prevalence of liver disease continues to climb alongside diabetes and obesity, the role of the primary care physician is evolving from referral maker to frontline manager.

We also report on a new use for artificial intelligence that could help eliminate some racial inequities in heart disease diagnoses.

Despite higher levels of specific IgE, Black patients undergo oral food challenge tests far less often than White patients and are more likely to tolerate them, indicating possible overdiagnosis.

News All Time

Biologic Evidence May Reshape Long-COVID Diagnosis and Care

Researchers have reported biologic abnormalities in long COVID, challenging the view that symptoms are primarily psychosomatic.

This Game Could Make You a Better Doctor: JAMA Study

A nightmare ER shift — and a little anger — led this doctor into a world of decision science, triage heuristics, and building a video game that makes doctors better.

S1 Episode 3: Don't Miss the Zebra: AI in ATTR-CM

ATTR-CM is the zebra hiding among the horses. AI may finally be the tool that finds it. Experts Drs Kevin Alexander and Lily Stern explore what's working, what's not, and what comes next.

Addressing Food Insecurity in CKD Care

Nutrition and food insecurity among CKD patients can lead to diets of high‑sodium, high‑phosphate convenience foods, yet simple clinic‑level interventions can improve dietary adherence and outcomes.

Intellia's Gene Therapy for Rare Disease cuts Swelling Attacks in Late-stage Trial

Intellia Therapeutics said on Monday its experimental gene-editing therapy reduced the frequency of swelling attacks in ⁠patients with a rare genetic disorder in a...

Treating ‘The Sinus’ in Primary Care

How to sort out a simple cold, allergic rhinitis, and chronic sinusitis.

FDA Proposes to Withdraw Amgen's Drug for Rare Autoimmune Diseases Over Effectiveness

The U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER) has proposed withdrawing approval of Amgen's drug for rare autoimmune diseases, citing...

BC’s Efforts to Contain Toxic Drugs Still Floundering

Critics say the government does not give effective strategies enough time or money to scale up and deliver robust outcomes.

South Carolina Declares End to Measles Outbreak After Nearly 1,000 Cases

South Carolina health officials have declared an end to a measles outbreak that sickened 997 people over ⁠six months, making it the largest single-location outbreak in the...

EU Expands Immunoglobulin Use for Measles Prophylaxis

The EMA has recommended expanding Privigen’s use to include measles pre- and postexposure prophylaxis in susceptible adults and children who cannot receive vaccination.

Stopping RAS Inhibitors Linked to Worse CKD Outcomes

Patients with chronic kidney disease are often taken off RAS inhibitors after declines in kidney function, but the risks may outweigh the benefits.

Infant Colic Linked to Risk for Later Food Allergies

Rates of peanut and tree nut allergy showed the most persistent associations with infant colic.

Novartis Gets European Commission Approval for Urticaria Drug

Novartis has ⁠received European Commission approval for its ⁠drug Rhapsido, an oral treatment ⁠for ‌chronic spontaneous urticaria.

Tips for Dermatologists to Guide GLP-1 Therapy

For many patients without a primary care provider, a dermatologist may be the only healthcare professional who can counsel them about minimizing metabolic disease risks with GLP-1 therapy.

HIV Infection Not Tied to Cancer Risk After Liver Transplant

Patients with HIV infection who receive a liver transplant may face a similar risk of developing new cancers as those without HIV infection.

Risk for Mortality and Complications High in Lupus

Patients with systemic lupus erythematosus have higher risks for mortality and complications than control individuals; Black patients face higher risks for mortality, diabetes, and other conditions.

Recommended News For You

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

TULSA Is Effective in Long-Term Prostate Cancer Control.

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans

The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.

Recommended Articles For You

A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer 

Liquid Biopsies Unveiling the Future of Precision Cancer Management by 2025 

A Closer Look at the Effects of Sickle Cell on Eyesight 

What Is A Normal Fibrinogen Level, And How Can It Affect Your Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Childhood brain tumors develop early in highly specialized nerve cells, research reveals

2.

Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries

3.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

4.

Obesity-related cancers are more likely in people who are obese in both healthy and unhealthy ways.

5.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

1.

Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025

2.

Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research

3.

Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence

4.

Exosomes in Cancer: A Novel Frontier for Therapy and Biomarker Discovery

5.

Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

5.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot